Testing
 
Project Tracking System
username    password    Login

 

 

Press Releases
  
 

 
8/22/2008
WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
August 22, 2008 – Shanghai, China – WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has promoted Dr. Rujian Ma to Vice President of Synthetic Chemistry.
8/17/2008 WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
8/1/2008 WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development
7/14/2008 Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry
7/11/2008 WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
7/10/2008 WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy
7/10/2008 WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
7/9/2008 WuXi AppTec VP and GM Invited to Join the AAMI Standards Board
7/2/2008 WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
6/24/2008 Covance and WuXi PharmaTech To Form A Joint Venture to Provide World-class Preclinical Services in China
Total 25   First Prev Next Last Page：1/3Page  10/Page

 
 
Copyright © 2008 WuXi PharmaTech Co., Ltd. All rights reserved.